-       Report 
- November 2024
-  250 Pages 
- Global 
   From       €3734EUR$4,175USD£3,285GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- October 2024
-  140 Pages 
- China 
   From       €3734EUR$4,175USD£3,285GBP 
          -       Report 
- November 2021
-  1165 Pages 
- Global 
   From       €5367EUR$6,000USD£4,721GBP 
             Neurogenomics is a field of genomics that focuses on the study of the genetic basis of neurological disorders. It combines the fields of neuroscience and genomics to identify genetic variants associated with neurological diseases. Neurogenomics research is used to develop new treatments and therapies for neurological disorders, such as Alzheimer's disease, Parkinson's disease, and autism. It also helps to identify genetic markers that can be used to diagnose and monitor neurological    diseases.
Neurogenomics is a rapidly growing field, with advances in technology allowing for more detailed analysis of genetic data. This has enabled researchers to identify genetic variants associated with neurological disorders, as well as to develop new treatments and therapies.
Some companies in the Neurogenomics market include Illumina, Thermo Fisher Scientific, Pacific Biosciences, and BGI. Show Less   Read more